Mobility during the post-partum period and viraemia in women living with HIV in South Africa.

Abstract

We investigated the association between travel and viraemia in post-partum women with human immunodeficiency virus on antiretroviral therapy (ART). Data are from a trial of post-partum ART delivery strategies. Women who initiated ART during pregnancy, were clinically stable with a viral load (VL) <400copies/ml and were <10weeks post-partum were enrolled at a primary care antenatal clinic in Cape Town, South Africa. Study visits at 3, 6, 12, 18 and 24months post-partum included questions about travel, defined as ≥1night spent outside of the city, and VL testing. Generalised mixed effects models assessed the association between travel and subsequent VL ≥400copies/ml. Among 402 women (mean age 29y, 35% born in the Western Cape), 69% reported one or more travel events over 24months. Being born beyond the Western Cape (adjusted odds ratio [aOR] 2.03 [95% confidence interval {CI} 1.49 to 2.77]), duration post-partum in months (aOR 1.03 [95% CI 1.02 to 1.05]) and living with the child (aOR 0.60 [95% CI 0.38 to 0.93]) were associated with travel. In multivariable analyses, a travel event was associated with a 92% increase in the odds of a VL ≥400copies/ml (aOR 1.92 [95% CI 1.19 to 3.10]). Interventions to support women on ART who travel are urgently required.